Biowise Limited - Limited company accounts 20.1
Biowise Limited - Limited company accounts 20.1
REGISTERED NUMBER: |
Biowise Limited |
Strategic Report, Report of the Directors and |
Financial Statements for the Year Ended 31st December 2021 |
Biowise Limited (Registered number: 04305295) |
Contents of the Financial Statements |
for the year ended 31st December 2021 |
Page |
Company Information | 1 |
Strategic Report | 2 |
Report of the Directors | 3 |
Report of the Independent Auditors | 5 |
Income Statement | 8 |
Other Comprehensive Income | 9 |
Balance Sheet | 10 |
Statement of Changes in Equity | 11 |
Notes to the Financial Statements | 12 |
Biowise Limited |
Company Information |
for the year ended 31st December 2021 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
Chartered Accountants |
Statutory Auditor |
Regent's Court |
Princess Street |
Hull |
East Yorkshire |
HU2 8BA |
BANKERS: |
10 Paragon Street |
Hull |
HU1 3ND |
Biowise Limited (Registered number: 04305295) |
Strategic Report |
for the year ended 31st December 2021 |
The directors present their strategic report of the company for the year ended 31 December 2021. The directors are pleased with the company's performance and results for the year. |
The principal activity of the group is treatment of residential organic waste serving long term Local Authority contracts through a combination of IVC, ASP and OWC composting technology. |
REVIEW OF BUSINESS |
The company has performed in line with forecast across all business activities. |
PRINCIPAL RISKS AND UNCERTAINTIES |
Like many businesses the most significant risk affecting the company are considered to be rising inflation, fuel and energy costs, all of which will present challenges to trading into 2022 and beyond. |
FUTURE DEVELOPMENT AND PERFORMANCE |
To maintain and improve profit levels over the short to medium term there will be a real focus on cost minimisation and improved efficiencies. This strategy will be complimented by ongoing carefully managed growth, striving to expand our client base in the north of England and regional areas beyond; especially where there are demonstrable synergies to existing skill-sets, facilities and profitability. |
KEY PERFORMANCE INDICATORS |
Week by week comparisons between previous year tonnage against the current year will be used to ensure the business stays on track. This enables time for intervention as required. Key cost drivers including fuel, electricity and offtakes will be monitored closely to ensure costs are kept to a minimum at no less than monthly intervals. |
The current portfolio of KPI's will continue to be formulated and reviewed on a monthly basis. |
As always safety, compliance and the environment form the keystone of any decision making. |
ON BEHALF OF THE BOARD: |
Biowise Limited (Registered number: 04305295) |
Report of the Directors |
for the year ended 31st December 2021 |
The directors present their report with the financial statements of the company for the year ended 31st December 2021. |
DIVIDENDS |
The total distribution of dividends for the year ended 31st December 2021 will be £61,134. |
DIRECTORS |
The directors shown below have held office during the whole of the period from 1st January 2021 to the date of this report. |
GOING CONCERN |
The company has net assets of £6,008,290 at 31 December 2021; made a profit before tax of £2,166,444 in the year; and is highly cash generative. Financial forecasts for the next two financial years show similar profitability and cash generation going forward and demonstrate the company's ability to service its debts and manage working capital with significant headroom. The directors are therefore satisfied that the financial statements should be prepared on a going concern basis. |
STATEMENT OF DIRECTORS' RESPONSIBILITIES |
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: |
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. |
Biowise Limited (Registered number: 04305295) |
Report of the Directors |
for the year ended 31st December 2021 |
AUDITORS |
The auditors, Smailes Goldie, will be proposed for re-appointment at the forthcoming Annual General Meeting. |
ON BEHALF OF THE BOARD: |
Report of the Independent Auditors to the Members of |
Biowise Limited |
Opinion |
We have audited the financial statements of Biowise Limited (the 'company') for the year ended 31st December 2021 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
In our opinion the financial statements: |
- | give a true and fair view of the state of the company's affairs as at 31st December 2021 and of its profit for the year then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
Basis for opinion |
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
Conclusions relating to going concern |
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
Other Matter |
The corresponding figures relating to the prior period were not audited. |
Other information |
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
Report of the Independent Auditors to the Members of |
Biowise Limited |
Opinions on other matters prescribed by the Companies Act 2006 |
In our opinion, based on the work undertaken in the course of the audit: |
- | the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
- | the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
Matters on which we are required to report by exception |
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors. |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of directors' remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit. |
Responsibilities of directors |
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so. |
Auditors' responsibilities for the audit of the financial statements |
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, anti-bribery, Environment Agency legislation, and health and safety legislation. An understanding of these laws and regulations and the extent of compliance was obtained through discussion with management and inspecting legal and regulatory correspondence. |
We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by making enquiries of management and considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations. |
To address the risk of fraud through management bias and override of controls, we: |
- | performed analytical procedures to identify any unusual or unexpected relationships; |
- | tested journal entries to identify unusual transactions; |
- | assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and |
- | investigated the rationale behind significant or unusual transactions. |
Report of the Independent Auditors to the Members of |
Biowise Limited |
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to: |
- | agreeing financial statement disclosures to underlying supporting documentation; |
- | reading the minutes of meetings of those charged with governance; |
- | enquiring of management as to actual and potential litigation and claims; and |
- | reviewing correspondence with relevant regulators and the limited liability partnership's legal advisors. |
Due to the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. |
The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission, or misrepresentation. |
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
Use of our report |
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
for and on behalf of |
Chartered Accountants |
Statutory Auditor |
Regent's Court |
Princess Street |
Hull |
East Yorkshire |
HU2 8BA |
Biowise Limited (Registered number: 04305295) |
Income Statement |
for the year ended 31st December 2021 |
2021 | 2020 |
Notes | £ | £ | £ | £ |
TURNOVER |
Cost of sales |
GROSS PROFIT |
Administrative expenses - impairment charges |
Administrative expenses - others |
2,020,679 | 1,437,209 |
2,369,950 | 2,589,502 |
Other operating income |
OPERATING PROFIT | 4 |
Interest receivable and similar income |
2,394,414 | 2,649,323 |
Interest payable and similar expenses | 5 |
PROFIT BEFORE TAXATION |
Tax on profit | 6 |
PROFIT FOR THE FINANCIAL YEAR |
Biowise Limited (Registered number: 04305295) |
Other Comprehensive Income |
for the year ended 31st December 2021 |
2021 | 2020 |
Notes | £ | £ |
PROFIT FOR THE YEAR |
OTHER COMPREHENSIVE INCOME | - | - |
TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
Biowise Limited (Registered number: 04305295) |
Balance Sheet |
31st December 2021 |
2021 | 2020 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 8 |
Tangible assets | 9 |
Investments | 10 |
CURRENT ASSETS |
Debtors | 11 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 12 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
13 |
( |
) |
( |
) |
PROVISIONS FOR LIABILITIES | 17 | ( |
) | ( |
) |
ACCRUALS AND DEFERRED INCOME | 18 | ( |
) |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 19 |
Revaluation reserve | 20 |
Retained earnings | 20 |
SHAREHOLDERS' FUNDS |
The financial statements were approved by the Board of Directors and authorised for issue on |
Biowise Limited (Registered number: 04305295) |
Statement of Changes in Equity |
for the year ended 31st December 2021 |
Called up |
share | Retained | Revaluation | Total |
capital | earnings | reserve | equity |
£ | £ | £ | £ |
Balance at 1st January 2020 |
Changes in equity |
Dividends | - | ( |
) | - | ( |
) |
Total comprehensive income | - |
Balance at 31st December 2020 |
Changes in equity |
Dividends | - | ( |
) | - | ( |
) |
Total comprehensive income | - |
Balance at 31st December 2021 |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements |
for the year ended 31st December 2021 |
1. | STATUTORY INFORMATION |
Biowise Limited is a |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
The financial statements continue to be prepared on a going concern basis. |
The significant accounting polices applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. |
Going concern |
The company has net assets of £6,008,290 at 31 December 2021; made a profit before tax of £2,166,444 in the year; and is highly cash generative. Financial forecasts for the next two financial years show similar profitability and cash generation going forward and demonstrate the company's ability to service its debts and manage working capital with significant headroom. The directors are therefore satisfied that the financial statements should be prepared on a going concern basis. |
Financial Reporting Standard 102 - reduced disclosure exemptions |
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland": |
• | the requirements of Section 7 Statement of Cash Flows; |
• | the requirement of paragraph 3.17(d); |
• | the requirement of paragraph 33.7. |
Preparation of consolidated financial statements |
The financial statements contain information about Biowise Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements. |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. The policies adopted for the recognition of turnover are as follows: |
When the outcome of a transaction can be estimated reliably, turnover from the provision of waste management services is recognised when the service has been provided. |
Intangible assets |
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
2. | ACCOUNTING POLICIES - continued |
Tangible fixed assets |
Freehold property | - |
Short leasehold | - |
Plant and machinery | - |
The company has taken the exemption conferred in section 35.10(c) of FRS 102 and used the fair value of freehold land at the date of transition as its deemed cost. |
Investments in subsidiaries |
Investments in subsidiaries are stated at cost less provision for impairment. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Research and development |
Expenditure on research and development is written off in the year in which it is incurred. |
Hire purchase and leasing commitments |
Assets obtained under hire purchase contracts are capitalised as tangible assets and depreciated over their useful lives. Obligations under such agreements are included in creditors net of finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period. |
Share based payments |
The cost of equity-settled transactions with employees is measured by reference to their fair value of the financial instrument granted at the date at which they are granted and is recognised as an expense over the vesting period, which starts once the vesting conditions have been met and ends once the relevant employee becomes fully entitled to the award. |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
3. | EMPLOYEES AND DIRECTORS |
2021 | 2020 |
£ | £ |
Wages and salaries |
Social security costs |
Other pension costs |
The average number of employees during the year was as follows: |
2021 | 2020 |
Direct labour |
2021 | 2020 |
£ | £ |
Directors' remuneration |
4. | OPERATING PROFIT |
The operating profit is stated after charging: |
2021 | 2020 |
£ | £ |
Other operating leases |
Depreciation - owned assets |
Loss on disposal of fixed assets |
Foreign exchange differences |
Impairment charge against investment in subsidiary (see note 10) |
Impairment charge against group loan |
5. | INTEREST PAYABLE AND SIMILAR EXPENSES |
2021 | 2020 |
£ | £ |
Bank interest |
Bank loan interest |
Hire purchase |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
6. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit for the year was as follows: |
2021 | 2020 |
£ | £ |
Current tax: |
UK corporation tax |
Corporation tax under-provided in previous years |
5,903 |
- |
Total current tax |
Deferred tax: |
Origination and reversal of timing differences |
Effect of changes in tax rates | 222,408 | - |
Over-provided previously | - | (30,065 | ) |
Total deferred tax |
Tax on profit |
Reconciliation of total tax charge included in profit and loss |
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below: |
2021 | 2020 |
£ | £ |
Profit before tax |
Profit multiplied by the standard rate of corporation tax in the UK of |
Effects of: |
Expenses not deductible for tax purposes |
Adjustments to tax charge in respect of previous periods | ( |
) |
Change in tax rates on opening deferred tax provision | 222,408 | - |
Impairment of assets not tax deductible | 107,368 | - |
Capital allowances super deduction | (1,199 | ) | - |
Group relief | - | (13,709 | ) |
Total tax charge | 758,616 | 430,686 |
UK corporation tax has been charged at 19% (2020: 19%). |
In the Spring Budget 2021, the Government announced that from 1st April 2023 the corporation tax rate will increase to 25%. The deferred tax provision has been based on the rates applicable to the years in which the timing differences reverse. |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
7. | DIVIDENDS |
2021 | 2020 |
£ | £ |
Ordinary shares of £1 each |
Interim |
8. | INTANGIBLE FIXED ASSETS |
Other |
intangibles |
£ |
COST |
At 1st January 2021 |
and 31st December 2021 |
AMORTISATION |
At 1st January 2021 |
and 31st December 2021 |
NET BOOK VALUE |
At 31st December 2021 |
At 31st December 2020 |
9. | TANGIBLE FIXED ASSETS |
Freehold | Short | Plant and |
property | leasehold | machinery | Totals |
£ | £ | £ | £ |
COST |
At 1st January 2021 |
Additions |
Disposals | ( |
) | ( |
) |
At 31st December 2021 |
DEPRECIATION |
At 1st January 2021 |
Charge for year |
Eliminated on disposal | ( |
) | ( |
) |
At 31st December 2021 |
NET BOOK VALUE |
At 31st December 2021 |
At 31st December 2020 |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
10. | FIXED ASSET INVESTMENTS |
Shares in |
group |
undertakings |
£ |
COST |
At 1st January 2021 |
Impairments | ( |
) |
At 31st December 2021 |
NET BOOK VALUE |
At 31st December 2021 |
At 31st December 2020 |
The company's investments at the Balance Sheet date in the share capital of companies include the following: |
Subsidiaries |
Registered office: Albion House, Albion Lane, Willerby, East Yorkshire, HU10 6TS. |
Nature of business: |
% |
Class of shares: | holding |
2021 | 2020 |
£ | £ |
Aggregate capital and reserves | ( |
) |
Loss for the year | ( |
) | ( |
) |
Registered office: Albion House, Albion Lane, Willerby, East Yorkshire, HU10 6TS. |
Nature of business: |
% |
Class of shares: | holding |
2021 | 2020 |
£ | £ |
Aggregate capital and reserves |
Registered office: Albion House, Albion Lane, Willerby, East Yorkshire, HU10 6TS. |
Nature of business: |
% |
Class of shares: | holding |
2021 | 2020 |
£ | £ |
Aggregate capital and reserves |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
10. | FIXED ASSET INVESTMENTS - continued |
Joint venture |
Registered office: Windermere MRF, Thomlinson Road, Hartlepool, TS25 1NS |
Nature of business: |
% |
Class of shares: | holding |
£ | £ |
Aggregate capital and reserves |
11. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2021 | 2020 |
£ | £ |
Trade debtors |
Amounts owed by group undertakings |
Other debtors |
Directors and shareholders' loans | 2,000,581 | - |
Prepayments |
12. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2021 | 2020 |
£ | £ |
Bank loans and overdrafts (see note 14) |
Other loans (see note 14) |
Hire purchase contracts (see note 15) |
Trade creditors |
Corporation tax |
Social security and other taxes |
Other creditors |
Accruals and deferred income |
13. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
2021 | 2020 |
£ | £ |
Bank loans (see note 14) |
Hire purchase contracts (see note 15) |
Shareholders' loans | - | 843,019 |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
14. | LOANS |
An analysis of the maturity of loans is given below: |
2021 | 2020 |
£ | £ |
Amounts falling due within one year or on demand: |
Bank loans |
Loans from related party companies |
Amounts falling due between one and two years: |
Bank loans |
Amounts falling due between two and five years: |
Bank loans |
Amounts falling due in more than five years: |
Repayable by instalments |
Bank loans | 883,419 | 1,118,796 |
15. | LEASING AGREEMENTS |
Minimum lease payments fall due as follows: |
Hire purchase | contracts |
2021 | 2020 |
£ | £ |
Gross obligations repayable: |
Within one year |
Between one and five years |
Finance charges repayable: |
Within one year |
Between one and five years |
Net obligations repayable: |
Within one year |
Between one and five years |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
15. | LEASING AGREEMENTS - continued |
Non-cancellable | operating leases |
2021 | 2020 |
£ | £ |
Within one year |
Between one and five years |
16. | SECURED DEBTS |
The following secured debts are included within creditors: |
2021 | 2020 |
£ | £ |
Bank loans |
Hire purchase contracts | 1,831,585 | 2,212,542 |
Shareholder loans | - | 843,019 |
The above debts are all secured by fixed and floating charges on all of the assets of the company. |
17. | PROVISIONS FOR LIABILITIES |
2021 | 2020 |
£ | £ |
Deferred tax |
Accelerated capital allowances | 1,042,015 | 771,193 |
Deferred |
tax |
£ |
Balance at 1st January 2021 |
Charge to Income Statement during year |
Balance at 31st December 2021 |
The expected net reversal of the deferred tax provision in 2022 is £91,320. |
18. | ACCRUALS AND DEFERRED INCOME |
Accruals and deferred income represents deferred capital grants. |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
19. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2021 | 2020 |
value: | £ | £ |
Ordinary | £1 | 120 | 120 |
Ordinary A | £1 | 10 | 10 |
130 | 130 |
20. | RESERVES |
Retained | Revaluation |
earnings | reserve | Totals |
£ | £ | £ |
At 1st January 2021 | 4,661,466 |
Profit for the year | - |
Dividends | ( |
) | - | ( |
) |
At 31st December 2021 | 6,008,160 |
21. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following advances and credits to a director subsisted during the years ended 31st December 2021 and 31st December 2020: |
2021 | 2020 |
£ | £ |
Balance outstanding at start of year |
Amounts advanced |
Amounts repaid | ( |
) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of year |
Loans made to the directors are on an interest free basis. |
22. | RELATED PARTY DISCLOSURES |
The company owed |
The above is a shareholder of Wastewise Holdings Limited, the parent company. |
23. | ULTIMATE CONTROLLING PARTY |
The ultimate parent company is Wastewise Holdings Limited, a company registered in the United Kingdom. The registered office is Albion House, Albion Lane, Willerby, East Yorkshire, HU10 6TS. Wastewise Holdings Limited is the only company in which the company's results are consolidated. |
J Landau is ultimate controlling party by virtue of his controlling stake in Wastewise Holdings Limited. |
Biowise Limited (Registered number: 04305295) |
Notes to the Financial Statements - continued |
for the year ended 31st December 2021 |
24. | SHARE-BASED PAYMENT TRANSACTIONS |
Certain employees participate in the Wastewise Holdings Limited 2018 EMI Scheme Option Plan. Options were granted on 28 March 2018 and lapse if not exercised within ten years of that date. The vesting condition require a change in ultimate control of the company. The vesting condition has not yet been met, so no share based payments expense has been recognised through the income statement to date. |
Options over 20 unissued ordinary shares of £1 each were outstanding at 31 December 2020 and 31 December 2021, with no options being capable of being exercised. No options were granted, forfeited, exercised or expired in the year. |
The exercise price on each option is £15,833.33 per ordinary share of £1 each. |